Renal manifestations are becoming a very important health problem in the developing world. In Sudan, the new cases account for about 70-140 thousand of inhabitants per year. Leading to reduced quality of life, these manifestations have negative social and economic impact on the population. This cross-sectional study was conducted in March 2016 to evaluate the anemia and thrombopathy in patients with end stage renal disease (ESRD) in Port Sudan hospital for surgery and hemodialysis, Red Sea State, Sudan. The study enrolled 70 patients, of whom 56 (80%) were males and 14 (20%) were females with the mean age being 51 years along with 70 healthy apparently adult subjects as control group of whom 53 (76%) were males and 17 (24%) were females with the mean age being 31 years. Unlike the control group, 51 (72%) of patients had anemia according to WHO criteria. Severe anemia (Hemoglobin concentration less than 7 g/dl) was detected in 28.6% of patients. Severe anemia has been more frequently (21.4%) in males than in females (7.1%). Likewise, the patient group showed a statistically significant decrease in platelet count (197.700±57.367) as compared to that of the control group (221.357±65.00) (P <0.024). In contrast, mean platelet volume (MPV) in the patient group showed a statistically significant increase (11.7±1.66) as compared to that of the control group (10.43±0.98) (P < 0.006). Thrombocytopenia was seen in 14.3% of patients. To conclude, this data could indicate that anemia and thrombopathy seen among these patients are attributed to the underlying renal impairment. This study recommends that all patients with unclear cause of anemia and/or thrombopathy should be checked for renal manifestations.
| Published in | American Journal of Laboratory Medicine (Volume 1, Issue 2) |
| DOI | 10.11648/j.ajlm.20160102.14 |
| Page(s) | 23-28 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Anemia, Thrombopathy, ESRD, Hemodialysis, Sudan
| [1] | Nurko S. Anemia in chronic kidney disease Causes, diagnosis, treatment. CCJM. 2006; 73 (3): 289–97. |
| [2] | Iseki k, Ikemiya Y, Iseki C and Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003; 63 (4):1468–74. |
| [3] | Martins Castro MC, Luders C, Elias RM, Abensur H, Romao Junior JE. High-efficiency short daily haemodialysis-morbidity and mortality rate in a long-term study. Nephrol Dial Transplant. 2006; 21 (8): 2232-8. |
| [4] | Gilbertson DT, Liu J, Xue JL, et al. Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015. J Am Soc Nephrol. 2005;16: 3736-41. |
| [5] | Mahon A. Epidemiology and classification of chronic kidney disease and management of diabetic nephropathy. Eur Endocr Rev. 2006; 2: 33-6. |
| [6] | Afshar R, Sanavi S, Salimi J. Epidemiology of Chronic Renal Failure in Iran: A Four Year Single Center Experience. Saudi J Kidney Dis Transpl. 2007; 18 (2): 191-4. |
| [7] | Suliman SM, Beliela MH, Hamza H. Dialysis and Transplantation in Sudan. Saudi J Kidney Dis Transpl. 1995; 6: 312-4. |
| [8] | Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol. 1997; 8 (12): 1921-9. |
| [9] | Portolés J, Gorriz JL, Rubio E, de Alvaro F, García F, Chivas AV, Aranda P, Castelao MA et al. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrol. 2013; 14 (2): 1–9. |
| [10] | Babitt JL, Lin HY (2012). Mechanism of anemia in CKD. J Am Soc Nephrol. 2012; 23: 1631–34. |
| [11] | Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semi Thrombo Hemost. 2004; 30 (5): 579–89. |
| [12] | Shirish M. Kawthalkar. Essentials of Haematology. 2ed edition. Jaypee Brothers Medical Publishers. New Delhi, India. 2013, pp 387. |
| [13] | National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002;39:1-266. |
| [14] | Stel VS, Kramer A, Zoccali C, Jager KJ. The 2007 ERA-EDTA registry annual report—a precis. NDT Plus. 2009: sfp126. |
| [15] | Shibiru T, Gudina EK, Habte B, Deribew A, Agonafer T. Survival patterns of patients on maintenance hemodialysis for end stage renal disease in Ethiopia: summary of 91 cases. BMC Nephrol. 2013; 14 (1): 127. |
| [16] | Ackoundou-N’Guessan K, Lagou D, Tia M, Gnionsahe D, Guei M. Risk factors for chronic renal failure in Ivory coast: a prospective study of 280 patients. Saudi J Kidney Dis Transplant. 2011; 22 (1): 185. |
| [17] | Diouf B, Ka E, Niang A, Diouf M, Mbengue M, Diop T. Etiologies of chronic renal insufficiency in a adult internal medicine service in Dakar. Dakar Med. 2000;45 (1): 62–5. |
| [18] | Elsharif M, Elsharif E. Causes of end-stage renal disease in Sudan: a single center experience. Saudi J Kidney Dis Transplant. 2011; 22 (2): 373. |
| [19] | Osman EM, Suleiman I, Elzubair AG. Patients knowledge of hypertension and its control in Eastern Sudan. East Afr Med J. 2007;84 (7): 324-8. |
| [20] | Henrich WL, Agodoa LE, Barrett B, Bennett WM, Blantz RC, Buckalew VM Jr, D’Agati VD, DeBroe ME, Duggin GG, Eknoyan G. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996; |
| [21] | 27 (1): 162 – 5. Chinwuba I, Uchenna I, Ngozi I. High prevalence of anemia in predialysis patients in Enugu, Nigeria. Nephrology Reviews, 2010; 2: 14. |
| [22] | McClellan W, Aronoff SL, Bolton WK. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004; 20: 1501–10. |
| [23] | Suega K, Bakta M, Tjok Gde Dharmayudha, Profile of Anemia in Chronic Renal Failure Patients: Comparision Between Predialyzed and Dialyzed Patients at The Division of Nephrology, Department of Internal Medicine, Sanglah Hospital, Denpasar, Bali, Indonesia. Indonesia Journal of Internal Medicine, 2005; 37: Original article. |
| [24] | Afshar R, Suzan Sanavi, Salimi J, Mahnaz Ahmadzaheh H. Hematological profile of Chronic Kidney disease in Iran, in Predialysis stages and after initiation of Haemodialysis. Saudi Journal Kidney Disease Transplant, 2009; 20: 368-371. |
| [25] | Akinsola A, Durosinmi MO, Akinola NO, The hematological profile of Nigerians with chronic renal failure. African Journal of Medicine and Medical Sciences. 2000; 29: 13-6. |
| [26] | Costa Elísio, Rocha Susana, Rocha-Pereira Petronila, Castro Elisabeth, Miranda Vasco, Faria Maria do Sameiro, Loureiro Alfredo, Quintanilha Alexandre, Belo Luís, and Santos-Silva Alice. Band 3 Profile as a Marker of Erythrocyte Changes in Chronic Kidney Disease Patients. Clin Chem J. 2008; 1: 57-63. |
| [27] | Pereira R, Costa E, Gonçalves M, Miranda V, do Sameiro Faria M, Quintanilha A, Belo L, Lima M, Santos-Silva A. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodial Int. 2010; 14 (3): 295-301. |
| [28] | Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial. 2009; 22 (3): 279-86. |
| [29] | Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood. 2001; 97 (4): 915-21. |
| [30] | Linthorst GE, Folman CC, van Olden RW, von dem Borne AE. Plasma thrombopoietin levels in patients with chronic renal failure. Hematol J. 2002; 3 (1): 38-42. |
| [31] | Ulusoy S, Ovali E, Aydin F, Erem C, Ozdemir F, Kaynar K. Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients. Med Princ Pract. 2004; 13 (6): 340-5. |
| [32] | Erdem Y, Haznedaroglu IC, Celik I, Yalcin AU, Yasavul U, Turgan C, Caglar S. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula. Nephrol Dial Transplant. 1996; 11 (7): 1299-305. |
| [33] | Ju HY, Kim JK, Hur SM, Woo SA, Park KA, Park MY, Choi SJ, Hwang SD. Could mean platelet volume be a promising biomarker of progression of chronic kidney disease? Platelets. 2015; 26: 143-147. |
APA Style
Bashir Abdrhman Bashir, Mohammed Omer Gibreel. (2016). Assessment of Anemia and Thrombopathy in Eastern Sudanese Patients with End Stage Renal Disease. American Journal of Laboratory Medicine, 1(2), 23-28. https://doi.org/10.11648/j.ajlm.20160102.14
ACS Style
Bashir Abdrhman Bashir; Mohammed Omer Gibreel. Assessment of Anemia and Thrombopathy in Eastern Sudanese Patients with End Stage Renal Disease. Am. J. Lab. Med. 2016, 1(2), 23-28. doi: 10.11648/j.ajlm.20160102.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajlm.20160102.14,
author = {Bashir Abdrhman Bashir and Mohammed Omer Gibreel},
title = {Assessment of Anemia and Thrombopathy in Eastern Sudanese Patients with End Stage Renal Disease},
journal = {American Journal of Laboratory Medicine},
volume = {1},
number = {2},
pages = {23-28},
doi = {10.11648/j.ajlm.20160102.14},
url = {https://doi.org/10.11648/j.ajlm.20160102.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20160102.14},
abstract = {Renal manifestations are becoming a very important health problem in the developing world. In Sudan, the new cases account for about 70-140 thousand of inhabitants per year. Leading to reduced quality of life, these manifestations have negative social and economic impact on the population. This cross-sectional study was conducted in March 2016 to evaluate the anemia and thrombopathy in patients with end stage renal disease (ESRD) in Port Sudan hospital for surgery and hemodialysis, Red Sea State, Sudan. The study enrolled 70 patients, of whom 56 (80%) were males and 14 (20%) were females with the mean age being 51 years along with 70 healthy apparently adult subjects as control group of whom 53 (76%) were males and 17 (24%) were females with the mean age being 31 years. Unlike the control group, 51 (72%) of patients had anemia according to WHO criteria. Severe anemia (Hemoglobin concentration less than 7 g/dl) was detected in 28.6% of patients. Severe anemia has been more frequently (21.4%) in males than in females (7.1%). Likewise, the patient group showed a statistically significant decrease in platelet count (197.700±57.367) as compared to that of the control group (221.357±65.00) (P <0.024). In contrast, mean platelet volume (MPV) in the patient group showed a statistically significant increase (11.7±1.66) as compared to that of the control group (10.43±0.98) (P < 0.006). Thrombocytopenia was seen in 14.3% of patients. To conclude, this data could indicate that anemia and thrombopathy seen among these patients are attributed to the underlying renal impairment. This study recommends that all patients with unclear cause of anemia and/or thrombopathy should be checked for renal manifestations.},
year = {2016}
}
TY - JOUR T1 - Assessment of Anemia and Thrombopathy in Eastern Sudanese Patients with End Stage Renal Disease AU - Bashir Abdrhman Bashir AU - Mohammed Omer Gibreel Y1 - 2016/10/11 PY - 2016 N1 - https://doi.org/10.11648/j.ajlm.20160102.14 DO - 10.11648/j.ajlm.20160102.14 T2 - American Journal of Laboratory Medicine JF - American Journal of Laboratory Medicine JO - American Journal of Laboratory Medicine SP - 23 EP - 28 PB - Science Publishing Group SN - 2575-386X UR - https://doi.org/10.11648/j.ajlm.20160102.14 AB - Renal manifestations are becoming a very important health problem in the developing world. In Sudan, the new cases account for about 70-140 thousand of inhabitants per year. Leading to reduced quality of life, these manifestations have negative social and economic impact on the population. This cross-sectional study was conducted in March 2016 to evaluate the anemia and thrombopathy in patients with end stage renal disease (ESRD) in Port Sudan hospital for surgery and hemodialysis, Red Sea State, Sudan. The study enrolled 70 patients, of whom 56 (80%) were males and 14 (20%) were females with the mean age being 51 years along with 70 healthy apparently adult subjects as control group of whom 53 (76%) were males and 17 (24%) were females with the mean age being 31 years. Unlike the control group, 51 (72%) of patients had anemia according to WHO criteria. Severe anemia (Hemoglobin concentration less than 7 g/dl) was detected in 28.6% of patients. Severe anemia has been more frequently (21.4%) in males than in females (7.1%). Likewise, the patient group showed a statistically significant decrease in platelet count (197.700±57.367) as compared to that of the control group (221.357±65.00) (P <0.024). In contrast, mean platelet volume (MPV) in the patient group showed a statistically significant increase (11.7±1.66) as compared to that of the control group (10.43±0.98) (P < 0.006). Thrombocytopenia was seen in 14.3% of patients. To conclude, this data could indicate that anemia and thrombopathy seen among these patients are attributed to the underlying renal impairment. This study recommends that all patients with unclear cause of anemia and/or thrombopathy should be checked for renal manifestations. VL - 1 IS - 2 ER -
Information
Email: